The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib
ATR 抑制剂 elimusertib 具有抗淋巴瘤活性,并与 PI3K 抑制剂 copanlisib 产生协同作用
期刊:British Journal of Haematology
影响因子:5.1
doi:10.1111/bjh.19218
Giulio Sartori, Chiara Tarantelli, Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Michele Mascia, Marilia Barreca, Alberto J Arribas, Luca Licenziato, Gaetanina Golino, Adele Ferragamo, Stefano Pileri, Giovanna Damia, Emanuele Zucca, Anastasios Stathis, Oliver Politz, Antje M Wengner, Francesco